Improving Disease Burden in Myelofibrosis: Changing the Natural History of the Disease.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 7, p. 715
- By:
- Publication type:
- Article
Works matching IS 08909091 AND DT 2013 AND VI 27 AND IP 7
Results: 18
1
2
Is IL-2 Still Indicated for Melanoma and RCC? What a Question to Ask!
- Published in:
- Oncology (08909091), 2013, v. 27, n. 7, p. 695
- By:
- Publication type:
- Article
3
A Large Cystic Pancreatic Mass in a 45-Year-Old Female.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
4
N+, M0 Prostate Cancer: Local Therapy for Systemic Disease.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 7, p. 661
- By:
- Publication type:
- Article
5
High-Dose Interleukin-2: Is It Still Indicated for Melanoma and RCC in an Era of Targeted Therapies?
- Published in:
- Oncology (08909091), 2013, v. 27, n. 7, p. 680
- By:
- Publication type:
- Article
6
Ruxolitinib for Myelofibrosis: From 'Palliation' to Prolongation of Survival.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 7, p. 717
- By:
- Publication type:
- Article
7
Management of Lymph Node-Positive Prostate Cancer: The Role of Surgery and Radiation Therapy.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 7, p. 647
- By:
- Publication type:
- Article
8
Clarifying the Use of Ruxolitinib in Patients With Myelofibrosis.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 7, p. 706
- By:
- Publication type:
- Article
9
Consultations IN Ethics.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
10
Lymph Node Positive Prostate Cancer: The Benefit of Local Therapy.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 7, p. 655
- By:
- Publication type:
- Article
11
Weighing the Evidence for Immune Therapy and Targeted Therapy in Renal Cancer and Melanoma.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 7, p. 691
- By:
- Publication type:
- Article
12
Extended Surgery for Retroperitoneal Sarcoma: Too Much Surgery for Some and Not Enough for Others?
- Published in:
- Oncology (08909091), 2013, v. 27, n. 7, p. 641
- By:
- Publication type:
- Article
13
Extended Surgery for Retroperitoneal Sarcoma: The Key to Maximizing the Potential for Cure and Survival.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 7, p. 640
- By:
- Publication type:
- Article
14
Two Paths Forward in Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 7, p. 638
- By:
- Publication type:
- Article
15
Targeted Therapy in Prostate Cancer: Is There Hope Beyond the Androgen Receptor?
- Published in:
- Oncology (08909091), 2013, v. 27, n. 7, p. 628
- By:
- Publication type:
- Article
16
Targeted Therapy in the Treatment of Castration-Resistant Prostate Cancer.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 7, p. 620
- By:
- Publication type:
- Article
17
'Economies of Scale' Yield Multiple Benefits for a Private, Physician-Run Oncology Practice.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 7, p. 616
- By:
- Publication type:
- Article
18
Remembering Old Lessons in Prostate Cancer: Avoiding Errors 'in PARPituity'.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 7, p. 595
- By:
- Publication type:
- Article